← FDA Drug Approvals (Drugs@FDA)

VANIQA

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2000-07-27

Drug application

FDA Application #

NDA021145

Application type

New Drug Application

Brand name

VANIQA

Generic name

Eflornithine Hydrochloride

Active ingredients

EFLORNITHINE HYDROCHLORIDE

Dosage form

CREAM

Route

TOPICAL

Marketing status

Discontinued

Sponsor

ABBVIE

First approval

2000-07-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown